Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Mechanism HSP90 inhibitors(Heat shock protein HSP90 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | NDA/BLA | - | 01 Dec 2021 | |
Breast Cancer | Phase 1 | KR | 30 Jan 2022 | |
Colorectal Cancer | Phase 1 | KR | 30 Jan 2022 | |
Liver Cancer | Phase 1 | KR | 30 Jan 2022 | |
Non-Small Cell Lung Cancer | Phase 1 | KR | 30 Jan 2022 | |
Ovarian Cancer | Phase 1 | KR | 30 Jan 2022 | |
Pancreatic Cancer | Phase 1 | KR | 30 Jan 2022 | |
Prostatic Cancer | Phase 1 | KR | 30 Jan 2022 | |
COVID-19 | Phase 1 | - | 01 Dec 2021 | |
Solid tumor | Phase 1 | - | 02 Mar 2020 |